A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Study Overview

We are working to understand if an investigational drug could be sage and potentially effective in promoting the repair of damaged tissue in the brain and spinal cord caused by MS, possibly impacting motor function.

Study Description

If you qualify and decide to take part, your total time would be about 17 visits over about 19 months.  What happens each visit will vary, but may include blood and urine samples, MRI scans and questionnaires.

  • IRB Number: 1810753783 (NEUR-ABBVIE-M18-918)
  • Research Study Identifier: TX10376
  • Principal Investigator: Jaison Grimes, MD

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176